| __timestamp | Celldex Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 1802274 |
| Thursday, January 1, 2015 | 33837000 | 2512761 |
| Friday, January 1, 2016 | 35979000 | 2894488 |
| Sunday, January 1, 2017 | 25003000 | 8096274 |
| Monday, January 1, 2018 | 19269000 | 7985229 |
| Tuesday, January 1, 2019 | 15426000 | 8994597 |
| Wednesday, January 1, 2020 | 14456000 | 29772000 |
| Friday, January 1, 2021 | 20488000 | 33907000 |
| Saturday, January 1, 2022 | 27195000 | 26579000 |
| Sunday, January 1, 2023 | 30914000 | 49868547 |
Unveiling the hidden dimensions of data
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Verona Pharma plc and Celldex Therapeutics, Inc. over the past decade, from 2014 to 2023.
Celldex Therapeutics, Inc. has shown a relatively stable SG&A expense trend, with a notable peak in 2016, where expenses reached approximately 36 million. In contrast, Verona Pharma plc's SG&A expenses have surged dramatically, especially in recent years, culminating in a 2023 figure that is nearly 28 times higher than in 2014. This sharp increase suggests a strategic shift, possibly towards aggressive market expansion or increased R&D investments.
These trends highlight the differing financial strategies of these companies, offering insights into their operational priorities and market positioning.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Celldex Therapeutics, Inc.
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
MannKind Corporation and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Travere Therapeutics, Inc. and Celldex Therapeutics, Inc.